US Patent 8933120 Enhanced bimatoprost ophthalmic solution
Patent 8933120 was granted and assigned to Allergan, Inc. on January, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8933120 Enhanced bimatoprost ophthalmic solution
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
